JP2019534891A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019534891A5 JP2019534891A5 JP2019529466A JP2019529466A JP2019534891A5 JP 2019534891 A5 JP2019534891 A5 JP 2019534891A5 JP 2019529466 A JP2019529466 A JP 2019529466A JP 2019529466 A JP2019529466 A JP 2019529466A JP 2019534891 A5 JP2019534891 A5 JP 2019534891A5
- Authority
- JP
- Japan
- Prior art keywords
- hiv
- subject
- antibody
- seq
- antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662374752P | 2016-08-13 | 2016-08-13 | |
| US62/374,752 | 2016-08-13 | ||
| PCT/US2017/046668 WO2018035001A1 (en) | 2016-08-13 | 2017-08-13 | Treatment and sustained virologic remission of hiv infection by antibodies to cd4 in haart stabilized patients |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019534891A JP2019534891A (ja) | 2019-12-05 |
| JP2019534891A5 true JP2019534891A5 (cg-RX-API-DMAC10.html) | 2020-09-24 |
Family
ID=61197201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019529466A Pending JP2019534891A (ja) | 2016-08-13 | 2017-08-13 | Ｈａａｒｔ安定化患者におけるｃｄ４に対する抗体によるｈｉｖ感染症の処置および持続的ウイルス学的寛解 |
Country Status (14)
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017312887A1 (en) * | 2016-08-13 | 2019-03-07 | United BioPharma, Inc. | Treatment and sustained virologic remission of hiv infection by antibodies to cd4 in haart stabilized patients |
| US12384830B2 (en) | 2017-06-02 | 2025-08-12 | Regents Of The University Of Minnesota | Compositions and methods for improving immunotherapy |
| CN113840912A (zh) * | 2019-05-16 | 2021-12-24 | 南京传奇生物科技有限公司 | 包含识别分子的工程化免疫细胞 |
| EP4381081A1 (en) | 2021-08-04 | 2024-06-12 | Sana Biotechnology, Inc. | Use of cd4-targeted viral vectors |
| WO2023114949A1 (en) | 2021-12-16 | 2023-06-22 | Sana Biotechnology, Inc. | Methods and systems of particle production |
| US20250082777A1 (en) | 2022-01-10 | 2025-03-13 | Sana Biotechnology, Inc. | Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses |
| WO2023150647A1 (en) | 2022-02-02 | 2023-08-10 | Sana Biotechnology, Inc. | Methods of repeat dosing and administration of lipid particles or viral vectors and related systems and uses |
| WO2023193015A1 (en) | 2022-04-01 | 2023-10-05 | Sana Biotechnology, Inc. | Cytokine receptor agonist and viral vector combination therapies |
| US20260027145A1 (en) | 2022-07-27 | 2026-01-29 | Sana Biotechnology, Inc. | Methods of transduction using a viral vector and inhibitors of antiviral restriction factors |
| WO2024044655A1 (en) | 2022-08-24 | 2024-02-29 | Sana Biotechnology, Inc. | Delivery of heterologous proteins |
| EP4590688A1 (en) | 2022-09-21 | 2025-07-30 | Sana Biotechnology, Inc. | Lipid particles comprising variant paramyxovirus attachment glycoproteins and uses thereof |
| WO2024119157A1 (en) | 2022-12-02 | 2024-06-06 | Sana Biotechnology, Inc. | Lipid particles with cofusogens and methods of producing and using the same |
| WO2024220597A2 (en) | 2023-04-18 | 2024-10-24 | Sana Biotechnology, Inc. | Digital droplet based assay for detecting replication competent lentiviral vector |
| AU2024274792A1 (en) | 2023-05-23 | 2025-10-23 | Sana Biotechnology, Inc. | Tandem fusogens and related lipid particles |
| WO2025184529A1 (en) | 2024-03-01 | 2025-09-04 | Sana Biotechnology, Inc. | Viral particles with fusogen display and related compositions and methods |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4381295A (en) | 1979-04-26 | 1983-04-26 | Ortho Pharmaceutical Corporation | Monoclonal antibody to human helper T cells and methods of preparing same |
| DE3828582A1 (de) | 1988-08-23 | 1990-03-01 | Max Planck Gesellschaft | Monoklonaler antikoerper zur inhibierung der infektion von zellen durch hiv-viren |
| EP0365209A3 (en) | 1988-10-17 | 1990-07-25 | Becton, Dickinson and Company | Anti-leu 3a amino acid sequence |
| JPH0725794B2 (ja) | 1990-03-23 | 1995-03-22 | 呉羽化学工業株式会社 | 新規なペプチド |
| DE69126301T2 (de) | 1990-11-27 | 1998-01-02 | Biogen, Inc., Cambridge, Mass. | Hiv-induzierte synzytien blockierender anti-cd-4-antikörper |
| JPH07503132A (ja) | 1991-12-17 | 1995-04-06 | ジェンファーム インターナショナル，インコーポレイティド | 異種抗体を産生することができるトランスジェニック非ヒト動物 |
| JPH06125783A (ja) | 1991-12-28 | 1994-05-10 | Chemo Sero Therapeut Res Inst | 組換え抗ｈｉｖ抗体およびその調製方法 |
| EP0746613B1 (en) | 1994-03-08 | 2006-05-24 | Memorial Sloan-Kettering Cancer Center | Recombinant humanized anti-fb5 antibodies |
| US5961976A (en) | 1996-06-03 | 1999-10-05 | United Biomedical, Inc. | Antibodies against a host cell antigen complex for pre- and post-exposure protection from infection by HIV |
| JP3231262B2 (ja) | 1996-06-05 | 2001-11-19 | 株式会社ビー・エム・エル | ヒトＴｈ１特異的タンパク質及びこれをコードする遺伝子、並びにこれに関連する形質転換体、組換えベクター及び抗体 |
| US5962319A (en) | 1997-05-19 | 1999-10-05 | Bml, Inc. | Human-Th1-specific protein, gene encoding the protein, transformants, recombinant vectors, and antibodies related to the gene |
| JPH10155489A (ja) | 1996-11-27 | 1998-06-16 | Asahi Chem Ind Co Ltd | 組換え抗体及びそれをコードする核酸 |
| EP0983303B1 (en) | 1997-05-21 | 2006-03-08 | Biovation Limited | Method for the production of non-immunogenic proteins |
| AU3733499A (en) | 1998-05-25 | 1999-12-13 | Asahi Kasei Kogyo Kabushiki Kaisha | Cell separation device and separation method |
| US6090388A (en) | 1998-06-20 | 2000-07-18 | United Biomedical Inc. | Peptide composition for prevention and treatment of HIV infection and immune disorders |
| AU3714800A (en) | 1999-03-02 | 2000-09-21 | Schering Corporation | Hiv therapy |
| DK1454137T3 (da) | 2001-12-11 | 2008-06-16 | Biotectid Gmbh | Anvendelse af en mærket ligand med specificitet for det humane CD4-molekyle |
| JP2003327536A (ja) | 2002-03-07 | 2003-11-19 | Kitasato Inst:The | ヒト免疫不全症候群ウイルスの感染、増殖抑制剤 |
| US20030211470A1 (en) | 2002-03-15 | 2003-11-13 | Olson William C. | CD4-IgG2-based salvage therapy of HIV-1 infection |
| US7501494B2 (en) | 2003-01-15 | 2009-03-10 | United Biomedical, Inc. | Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection |
| JP5020941B2 (ja) | 2005-05-02 | 2012-09-05 | マイメティクス コーポレーション | Ｈｉｖに対して中和活性を有するがｉｌ２には中和活性を有さない抗体又はその断片 |
| RU2393873C2 (ru) | 2005-05-02 | 2010-07-10 | Майметикс Корпорейшн | Антитело или его фрагмент, имеющие нейтрализующую активность в отношении вич, но не в отношении il2 |
| US20090214569A1 (en) | 2005-08-25 | 2009-08-27 | Government Of The Us, As Represented By The Secretary, Dept. Of Health & Human Services | Use of HIV envelope/CD4 complexes for the generation antibodies |
| WO2007094983A2 (en) | 2006-02-03 | 2007-08-23 | Tanox, Inc. | Methods and compositions for the inhibition of hiv infection of t cells |
| WO2014039840A1 (en) | 2012-09-07 | 2014-03-13 | Baylor Research Institute | Hiv vaccine compositions and methods |
| CA2906566C (en) | 2013-03-14 | 2024-09-10 | Macrogenics, Inc. | Immunoreactive bispecific molecules at immune effector cells expressing an activation receptor |
| EP3003355A1 (en) * | 2013-05-24 | 2016-04-13 | Cooper Human Systems LLC | Methods and compositions for treatment of hiv infection |
| US11180555B2 (en) * | 2014-09-16 | 2021-11-23 | Ubi Us Holdings, Llc. | Antibodies directed against CD4 for the treatment and functional cure of HIV |
| AU2017312887A1 (en) * | 2016-08-13 | 2019-03-07 | United BioPharma, Inc. | Treatment and sustained virologic remission of hiv infection by antibodies to cd4 in haart stabilized patients |
-
2017
- 2017-08-13 AU AU2017312887A patent/AU2017312887A1/en not_active Abandoned
- 2017-08-13 US US16/325,361 patent/US11292839B2/en active Active
- 2017-08-13 CN CN201780050119.1A patent/CN109996815A/zh active Pending
- 2017-08-13 KR KR1020197007296A patent/KR20190071677A/ko not_active Ceased
- 2017-08-13 EP EP17841919.8A patent/EP3497133A4/en not_active Withdrawn
- 2017-08-13 MX MX2019001814A patent/MX2019001814A/es unknown
- 2017-08-13 BR BR112019002734-3A patent/BR112019002734A2/pt unknown
- 2017-08-13 CA CA3033728A patent/CA3033728A1/en active Pending
- 2017-08-13 WO PCT/US2017/046668 patent/WO2018035001A1/en not_active Ceased
- 2017-08-13 SG SG11201901203PA patent/SG11201901203PA/en unknown
- 2017-08-13 SG SG10202100268RA patent/SG10202100268RA/en unknown
- 2017-08-13 JP JP2019529466A patent/JP2019534891A/ja active Pending
- 2017-08-13 RU RU2019106804A patent/RU2019106804A/ru not_active Application Discontinuation
- 2017-08-14 TW TW106127443A patent/TW201808998A/zh unknown
-
2019
- 2019-03-05 ZA ZA2019/01374A patent/ZA201901374B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11292839B2 (en) | Treatment and sustained virologic remission of HIV infection by antibodies to CD4 in HAART stabilized patients | |
| JP6857498B2 (ja) | 癌を処置するための併用方法 | |
| AU2021203071B2 (en) | Treatment and functional cure of HIV infection by monoclonal antibodies to CD4 mediating competitive HIV entry inhibition | |
| US12427184B2 (en) | Treatment of immunosuppressed subjects | |
| Madan et al. | Molecular umbrellas: a novel class of candidate topical microbicides to prevent human immunodeficiency virus and herpes simplex virus infections | |
| JP2022514561A5 (cg-RX-API-DMAC10.html) | ||
| US20250059280A1 (en) | Methods of treating human immunodeficiency virus (hiv) disease | |
| CN109833480A (zh) | 靶向nk细胞免疫检查点治疗感染性疾病的方法 | |
| US20220016079A1 (en) | Combination treatment of hiv infections | |
| JP2022520817A5 (cg-RX-API-DMAC10.html) | ||
| TW202540166A (zh) | 用於治療自體免疫性疾病／自體免疫性病症的ｃｄ１９選擇性ｔ細胞接合分子 | |
| Rizza et al. | Novel HIV drugs and drug delivery strategies. A report from the 2018 Conference on Retroviruses and Opportunistic Infections. Boston, Massachusetts, USA-March 4-7, 2018 | |
| Diaz-Torne et al. | AB0424 Il-6 receptor blockade induced a different immune response in rheumatoid arthritis patients with and without remission | |
| D'Cruz et al. | Recent advances in anogenital antiretroviral microbicides and multimodal delivery systems. | |
| HK40003703A (en) | Treatment and sustained virologic remission of hiv infection by antibodies to cd4 in haart stabilized patients | |
| RU2008106786A (ru) | Способы снижения вирусной нагрузки у пациентов, инфицированных вич-1 | |
| HK1114791A (en) | Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome | |
| HK1115064A (en) | Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |